Epstein-Barr virus and breast cancer: Serological study in a high-incidence area of nasopharyngeal carcinoma
By: He JR, Tang LY, Yu DD, Su FX, Song EW, Lin Y, Wang SM, Lai GC, Chen WQ, Ren ZF.

The School of Public Health, Sun Yat-Sen University, 74 Zhongshan 2nd Rd., Guangzhou 510080, China.
Cancer Lett. 2011 Oct 28; 309(2):128-36. Epub 2011 Jun 24.

Abstract

We investigated IgA and IgG levels against EBV viral capsid antigen (VCA) and nuclear antigen-1 (EBNA-1) in serum of 223 women with breast cancer (BC) and 309 controls in Guangzhou, China. VCA IgA levels were significantly associated with an elevated risk of BC, with adjusted ORs (95%CIs) of 1.70 (1.05-2.76) (seropositivity) and 2.21 (1.11-4.40) (unit increases in OD value). This association was stronger among young, lean, and HER2+ women. The EBNA-1 IgA levels in OD value, but not seropositivity, were associated with an increased risk of BC among ER+, PR+, and HER2+ patients. None of the IgG variables was related to BC. These results suggest the EBV association with BC in an endemic area of nasopharyngeal carcinoma.

Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

PMID: 21724319 Source: National Library of Medicine.







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements